Cargando…
Clinical impact of normal alanine aminotransferase on direct‐acting antiviral outcome in patients with chronic hepatitis C virus infection
BACKGROUND AND AIMS: This study aimed to clarify the clinical picture of hepatitis C virus (HCV) carriers with normal alanine aminotransferase (CNALT) and those with ALT elevation (non‐CNALT) under direct‐acting antivirals (DAAs). METHODS: We enrolled 1002 patients with HCV (427 men, median age: 69 ...
Autores principales: | Joshita, Satoru, Sugiura, Ayumi, Umemura, Takeji, Yamazaki, Tomoo, Fujimori, Naoyuki, Matsumoto, Akihiro, Usami, Yoko, Tanaka, Eiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411565/ https://www.ncbi.nlm.nih.gov/pubmed/32782941 http://dx.doi.org/10.1002/jgh3.12296 |
Ejemplares similares
-
Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C
por: Yamazaki, Tomoo, et al.
Publicado: (2018) -
Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study
por: Umemura, Takeji, et al.
Publicado: (2019) -
Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C
por: Yamazaki, Tomoo, et al.
Publicado: (2017) -
Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
por: Fujimori, Naoyuki, et al.
Publicado: (2018) -
Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis
por: Kimura, Takefumi, et al.
Publicado: (2018)